Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 1/2 1

Status

Recruiting 191Completed 71Active not recruiting 69Not yet recruiting 43Terminated 16Enrolling by invitation 4Suspended 2No longer available 1Available 1

Sponsor Class

OTHER 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1Sarcoma 1Other solid neoplasm 1Other 1Breast 1

Conditions

Neoplasms 51Breast Neoplasms 40Colorectal Neoplasms 26Prostatic Neoplasms 22Lung Neoplasms 18Carcinoma, Non-Small-Cell Lung 15Carcinoma, Hepatocellular 15Stomach Neoplasms 14Brain Neoplasms 11Hematologic Neoplasms 10Pancreatic Neoplasms 9Colonic Neoplasms 9Uterine Cervical Neoplasms 8Urinary Bladder Neoplasms 8Lymphoma, Follicular 8Head and Neck Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Ovarian Neoplasms 7Melanoma 7Liver Neoplasms 7Leukemia, Myeloid, Acute 7Disease 7Anxiety Disorders 7Myasthenia Gravis 6Multiple Myeloma 6Barrett Esophagus 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Rectal Neoplasms 5Lymphoma, Non-Hodgkin 5

Interventions

Stents 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Esophageal Neoplasms × 1 year × Clear all
NCT06437288 2026-05-22

Hematoporphyrin Photodynamic Therapy for Esophageal Cancer

Sun Yat-sen University

Phase 4 Enrolling by invitation
198 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06862479 2026-05-06

ES-LCCE-UDFM

Unidade Local de Saúde Santa Maria

Enrolling by invitation
180 enrolled
GastrointestinalOther

Esophageal Neoplasms, Fistula, Obesity, Obesity, Morbid, Stomach Neoplasms, Anastomotic Leak

NCT07371247 2026-01-27

Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy

The First Affiliated Hospital with Nanjing Medical University

Phase EARLY_PHASE1 Enrolling by invitation
65 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06603987 2025-11-19

Using CICS-1 and SPM-011 and ï¼»18Fï¼½FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Stella Pharma Corporation

Phase 1/2 Enrolling by invitation
30 enrolled
BreastGastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡